WallStreetZenWallStreetZen

NASDAQ: MRKR
Marker Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their MRKR stock forecasts and price targets.

Forecast return on equity

Is MRKR forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.81%

Forecast return on assets

Is MRKR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MRKR revenue growth forecast

How is MRKR forecast to perform vs Biotechnology companies and vs the US market?
Company
272.67%
Industry
37.64%
Market
10.1%
MRKR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MRKR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MRKR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MRKR$4.19N/AN/A
OCUP$1.51$20.00+1,224.50%Strong Buy
BCLI$0.54N/AN/A
XLO$1.10N/AN/A
ICCC$5.03N/AN/A

Marker Therapeutics Stock Forecast FAQ

What is MRKR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MRKR) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Marker Therapeutics stock.

What is MRKR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MRKR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.